Central European Journal of Medicine

, Volume 8, Issue 6, pp 713–719 | Cite as

Management of acute streptococcal pharyngitis: still the subject of controversy

  • Elżbieta Mazur
Review Article


Although most cases of acute pharyngitis are viral in origin, antibiotics are overused in its treatment. Streptococcus pyogenes (group A streptococcus, GAS), the principal bacterial pathogen of acute sore throat, is responsible for merely 5–30% of cases. Moreover, GAS pharyngitis is currently the only commonly occurring form of acute pharyngitis for which antibiotic therapy is definitely indicated. Therefore the differentiation between GAS pharyngitis and that of viral etiology is crucial. Accordingly, scientific societies as well as respected advisory bodies in Europe and North America, issued guidelines for the management of acute pharyngitis with the aim of minimizing unnecessary antibiotic prescriptions in its treatment. The aim of this review work is to confront the state of the art in acute GAS pharyngitis diagnosis and treatment with different approaches to its management represented by current European and North American guidelines. Although based on scientific evidence, international guidelines differ substantially in opinions whether GAS pharyngitis diagnosis should be based on microbiological testing, clinical algorithm or a combination of both. On the other hand, some European guidelines consider GAS pharyngitis to be a mild, self-limiting disease that does not require a specific diagnosis or antimicrobial treatment except in high-risk patients. There is an agreement among guidelines that if antibiotic therapy is indicated, phenoxymethyl penicillin should be the drug of choice to treat GAS pharyngitis.


Group A streptococcus (GAS) Pharyngitis Guidelines Rapid antigen detection test (RADT) Throat culture Penicillin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Wessels MR. Clinical practice. Streptococcal pharyngitis. N Engl J Med., 2011, 364, 648–655PubMedCrossRefGoogle Scholar
  2. [2]
    Stjernquist-Desatnik A, Orrling A. Pharyngotonsillitis. Periodontol. 2000, 2009, 49: 140–150PubMedCrossRefGoogle Scholar
  3. [3]
    Brahmadathan KN, Gladstone P. Microbiological diagnosis of streptococcal pharyngitis: lacunae and their implications. Indian J Med Microbiol., 2006, 24, 92–96PubMedCrossRefGoogle Scholar
  4. [4]
    Fretzayas A, Moustaki M, Kitsiou S, Nychtari G, Nicolaidou P. The clinical pattern of group C streptococcal pharyngitis in children. J Infect Chemother., 2009, 15, 228–232PubMedCrossRefGoogle Scholar
  5. [5]
    Tiemstra J, Miranda RLF. Role of non-group A streptococci in acute pharyngitis. J Am Board Fam Med., 2009, 22, 663–669PubMedCrossRefGoogle Scholar
  6. [6]
    Lindbaek M, Høiby EA, Lermark G, Steinsholt IM, Hjortdahl P. Clinical symptoms and signs in sore throat patients with large colony variant beta-haemolytic streptococci groups C or G versus group A. Br J Gen Pract., 2005, 55, 615–619PubMedGoogle Scholar
  7. [7]
    Hryniewicz W, Ozorowski T, Radzikowski A, Zielonka TM, Albrecht P, Lukas W et al. Rekomendacje postępowania w pozaszpitalnych zakażeniach układu oddechowego 2010. (in Polish)Google Scholar
  8. [8]
    Chazan B, Shaabi M, Bishara E, Colodner R, Raz R. Clinical predictors of streptococcal pharyngitis in adults. Isr Med Assoc J., 2003, 5, 413–415PubMedGoogle Scholar
  9. [9]
    Barash J. Group A streptococcal throat infection — to treat or not to treat? Acta Paediatr., 2009, 98, 434–436PubMedCrossRefGoogle Scholar
  10. [10]
    Bisno AL, Peter GS, Kaplan EL. Diagnosis of strep throat in adults: are clinical criteria really good enough? Clin Infect Dis., 2002, 35, 126–129PubMedCrossRefGoogle Scholar
  11. [11]
    Moro ML, Marchi M, Gagliotti C, Mario SD, Resi D, “Progetto bambini a antibiotici [ProBA]” Regional Group. Why do paediatricians prescribe antibiotics? Result of an Italian regional project. BMC Pediatr 2009, 9, 69. PubMedCrossRefGoogle Scholar
  12. [12]
    Nascimento-Carvalho CM. Outpatient antibiotic therapy as a predisposing factor for bacterial resistance: a rational approach to airway infections. J Pediatr (Rio J)., 2006, 82(5 Suppl), S146-S152Google Scholar
  13. [13]
    Panasiuk L, Lukas W, Paprzycki P, Verheij T, Godycki-Ćwirko M, Chlabicz S. Antibiotics in the treatment of upper respiratory tract infections in Poland. Is there any improvement? J Clin Pharm Ther., 2010, 35, 665–669PubMedCrossRefGoogle Scholar
  14. [14]
    Goossens H, Ferech M, Stichele RV, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a crossnational database study. Lancet., 2005, 365, 579–587PubMedGoogle Scholar
  15. [15]
    Fernández González N, Herrero-Morín JD, Solís Sánchez G, Pérez Méndez C, Molinos Norniella C, Pardo de la Vega R et al. Variability of antibiotic treatment in paediatric acute pharyngotonsillitis in Asturias, Spain. Arch Argent Pediatr., 2012, 110, 207–213 (in Spanish)PubMedCrossRefGoogle Scholar
  16. [16]
    Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012, 55, 1279–1282. PubMedCrossRefGoogle Scholar
  17. [17]
    ESCMID Sore Throat Guideline Group, Pelucchi C, Grigoryan L, Galeone C, Esposito S, Huovinen P, Little P et al. ESCMID guideline for the management of acute sore throat. Clin Microbiol Infect., 2012, 18(Suppl. 1), 1–28PubMedCrossRefGoogle Scholar
  18. [18]
    Chiappini E, Principi N, Mansi N, Serra A, De Masi S, Camaioni A et al; Italian Panel on the Management of Pharyngitis in Children. Management of acute pharyngitis in children: summary of the Italian National Institute of Health guidelines. Clin Ther., 2012, 34, 1442–1458PubMedCrossRefGoogle Scholar
  19. [19]
    British Columbia Ministry of Science. Sore throat diagnosis and management. 2003. Scholar
  20. [20]
    Systemic antibiotic treatment in upper and lower respiratory tract infections: official French guidelines. Agence Française de Sécurité Sanitaire des Produits de Santé. Clin Microbiol Infect., 2003, 9, 1162–1178Google Scholar
  21. [21]
    National Guideline Clearinghouse. Finnish Medical Society Duodecim. Tonsillitis and pharyngitis in children 2007. Google Scholar
  22. [22]
    National Institute for Health and Clinical Excellence. Respiratory tract infections — antibiotic prescribing. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. NICE clinical guideline 69. 2008. Google Scholar
  23. [23]
    Scottish Intercollegiate Guidelines Network. Management of sore throat and indication for tonsillectomy. A national clinical guideline 2010. Google Scholar
  24. [24]
    Starreveld JS, Zwart S, Boukes FS, Wiersma T, Goudswaard AN. Summary of the practice guideline “Sore throat” (second revision) from the Dutch College of General Practitioners. Ned Tijdschr Geneeskd., 2008, 152, 431–435 (in Dutch)PubMedGoogle Scholar
  25. [25]
    Chevalier P, De Sutter A. Guide belge des traitements anti-infectieux en pratique ambulatoire. Belgian Antimicrobial Policy Coordination Committee. 2008. (in French)Google Scholar
  26. [26]
    Snow V, Mottur-Pilson C, Cooper RJ, Hoffmann JR; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine; Centers for Disease Control. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med., 2001, 134, 506–508PubMedCrossRefGoogle Scholar
  27. [27]
    Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009, 119, 1541–1551PubMedCrossRefGoogle Scholar
  28. [28]
    Piñeiro Pérez R, Hijano Bandera F, Álvez González F, Fernández Landaluce A, Silva Rico JC, Pérez Cánovas C et al. Consensus document on the diagnosis and treatment of acute tonsillopharyngitis. An Pediatr (Barc)., 2011, 75, 342.e1–13 (in Spanish)Google Scholar
  29. [29]
    Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making., 1981, 1, 239–346PubMedCrossRefGoogle Scholar
  30. [30]
    McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ., 1998, 158, 75–83PubMedGoogle Scholar
  31. [31]
    Breese BB. A simple scorecard for the tentative diagnosis of streptococcal pharyngitis. Am J Dis Child., 1977, 131, 514–517PubMedGoogle Scholar
  32. [32]
    Attia MW, Zaoutis T, Klein JD, Meier FA. Performance of a predictive model for streptococcal pharyngitis in children. Arch Pediatr Adolesc Med., 2001, 155, 687–691PubMedCrossRefGoogle Scholar
  33. [33]
    Walsh BT, Bookheim WW, Johnson RC, Tompkins RK. Recognition of streptococcal pharyngitis in adults. Arch Intern Med., 1975, 135, 1493–1497PubMedCrossRefGoogle Scholar
  34. [34]
    Aalbers J, O’Brien KK, Chan WS, Falk GA, Teljeur C, Dimitrov BD et al. Predicting streptococcal pharyngitis in adults in primary care: a systemic review of the diagnostic accuracy of symptoms and signs and validation of the Centor score. BMC Medicine 2011, 9:67 PubMedCrossRefGoogle Scholar
  35. [35]
    Shaikh N, Swaminathan N, Hooper EG. Accuracy and precision of the signs and symptoms of streptococcal pharyngitis in children: a systematic review. J Pediatr., 2012, 160, 487–493PubMedCrossRefGoogle Scholar
  36. [36]
    Ebell MH, Smith MA, Barry HC, Ives K, Carey M. The rational clinical examination. Does this patient have strep throat? JAMA., 2000, 284, 2912–2918PubMedCrossRefGoogle Scholar
  37. [37]
    McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA., 2004, 291, 1587–1595PubMedCrossRefGoogle Scholar
  38. [38]
    Gerber MA, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev., 2004, 17, 571–580PubMedCrossRefGoogle Scholar
  39. [39]
    van der Veen EL, Sanders EAM, Videler WJM, van Staaij BK, van Benthem PPG, Schilder AGM. Optimal site for throat culture: tonsillar surface versus posterior pharyngeal wall. Eur Arch Otorhinolaryngol., 2006, 263, 750–753PubMedCrossRefGoogle Scholar
  40. [40]
    Johansson L, Månsson NO. Rapid test, throat culture and clinical assessment in the diagnosis of tonsillitis. Fam Pract., 2003, 20, 108–111PubMedCrossRefGoogle Scholar
  41. [41]
    Lasseter GM, McNulty CAM, Hobbs FDR, Mant D, Little P on behalf of the PRISM investigators. In vitro evaluation of five rapid antigen detection tests for group A beta-haemolytic streptococcal sore throat infections. Fam Pract., 2009, 26: 437–444PubMedCrossRefGoogle Scholar
  42. [42]
    Ruiz-Aragón J, Rodrígues López R, Molina Linde JM. Evaluation of rapid methods for detecting Streptococcus pyogenes. Systemic review and meta-analysis. An Pediatr (Barc)., 2010, 72, 391–402 (in Spanish)PubMedCrossRefGoogle Scholar
  43. [43]
    Tanz RR, Gerber MA, Kabat W, Rippe J, Seshadri R, Shulman ST. Performance of a rapid antigen-detection test and throat culture in community pediatric offices: implications for management of pharyngitis. Pediatrics., 2009, 123: 437–444PubMedCrossRefGoogle Scholar
  44. [44]
    Edmonson MB, Farwell KR. Relationship between the clinical likelihood of group A streptococcal pharyngitis and the sensitivity of a rapid antigen-detection test in a pediatric practice. Pediatrics., 2005, 115, 280–285PubMedCrossRefGoogle Scholar
  45. [45]
    Baltimore RS. Re-evaluation of antibiotic treatment of streptococcal pharyngitis. Curr Opin Pediatr., 2010, 22: 77–82PubMedCrossRefGoogle Scholar
  46. [46]
    Kaplan EL. The group A streptococcal upper respiratory tract carrier state: an enigma. J Pediatr., 1980, 97, 337–345PubMedCrossRefGoogle Scholar
  47. [47]
    Gerber MA. Diagnosis and treatment of pharyngitis in children. Pediatr Clin North Am., 2005, 52, 729–747PubMedCrossRefGoogle Scholar
  48. [48]
    Shulman ST, Gerber MA. So what’s wrong with penicillin for strep throat? Pediatrics., 2004, 113: 1816–1819PubMedCrossRefGoogle Scholar
  49. [49]
    Bisno AL. Are cephalosporins superior to penicillin for treatment of acute streptococcal pharyngitis? Clin Infect Dis., 2004, 38, 1535–1537PubMedCrossRefGoogle Scholar
  50. [50]
    Casey JR. Selecting the optimal antibiotic in the treatment of group A beta-hemolytic streptococci pharyngitis. Clin Pediatr., 2007, 46(4 suppl), 25S–35SCrossRefGoogle Scholar
  51. [51]
    Kaplan EL, Johnson DR. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics., 2001, 108, 1180–1186PubMedCrossRefGoogle Scholar
  52. [52]
    Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics., 2004, 113, 866–882PubMedCrossRefGoogle Scholar
  53. [53]
    Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis., 2004, 38, 1526–1534PubMedCrossRefGoogle Scholar
  54. [54]
    Gerber MA, Tanz RR, Kabat W, Bell GL, Siddiqui PN, Lerer TJ et al. Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics., 1999, 104(4 Pt 1): 911–917PubMedCrossRefGoogle Scholar
  55. [55]
    Hoye S, Frich J, Lindbaek M. Delayed prescribing for upper respiratory tract infections: a qualitative study of GP’s views and experiences. Br J Gen Pract., 2010, 60, 907–912PubMedCrossRefGoogle Scholar
  56. [56]
    Centor RM, Allison JJ, Cohen SJ. Pharyngitis management: defining the controversy. J Gen Intern Med., 2007, 22, 127–130PubMedCrossRefGoogle Scholar
  57. [57]
    Clegg HW, Ryan AG, Dallas SD, Kaplan EL, Johnson DR, Norton HJ et al. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial. Pediatr Infect Dis J., 2006, 25, 761–767PubMedCrossRefGoogle Scholar
  58. [58]
    Lennon DR, Farrell E, Martin DR, Stewart JM. Once-daily amoxicillin versus twice-daily penicillin V in group A beta-hemolytic streptococcal pharyngitis. Arch Dis Child. 2008, 93, 474–478PubMedCrossRefGoogle Scholar
  59. [59]
    Gracia M, Díaz C, Coronel P, Gimeno M, García-Rodas R, Rodríguez-Cerrato V et al. Antimicrobial susceptibility of Streptococcus pyogenes in central, eastern and baltic European countries, 2005 to 2006: the cefditoren surveillance program. Diagn Microbiol Infect Dis., 2009, 64: 52–56PubMedCrossRefGoogle Scholar
  60. [60]
    Tanz RR, Shulman ST, Shortridge VD, Kabat W, Kabat K, Cederlund E et al.; North American Streptococcal Pharyngitis Surveillance Group. Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin Infect Dis., 2004, 39, 1794–1801Google Scholar

Copyright information

© Versita Warsaw and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Medical Microbiology DepartmentMedical University of LublinLublinPoland

Personalised recommendations